Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Warren Windram

Podiatrist, Foot & Ankle Surgery Fort Lauderdale, FL Doctor of Podiatric Medicine

NPI 1407819949 CMS profile 244649

1601 S Andrews Ave Fl 2, Fort Lauderdale, FL 33316

Open in the dashboard

General payments

$15,713

214 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Warren Windram of Fort Lauderdale, FL is reported in the CMS Open Payments database as having received $15,713 across 214 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,962 20
2024 General $479 4
2023 General $1,460 15
2022 General $3,112 28
2021 General $1,696 40
2020 General $538 32
2019 General $6,466 75

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Warren Windram
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Warren Windram were reported at $1,962. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Warren Windram Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $6,466 $389 $118–$1,406 $163
2020 $538 $191 $62–$691 $114
2021 $1,696 $329 $104–$1,341 $132
2022 $3,112 $419 $125–$1,611 $149
2023 $1,460 $377 $128–$1,164 $160
2024 $479 $394 $134–$1,168 $164
2025 $1,962 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $2,697 28 payments
  2. Zimmer Biomet Holdings, Inc. $2,335 34 payments
  3. Wright Medical Technology, Inc. $2,160 14 payments
  4. Paragon 28, Inc. $1,527 11 payments
  5. Orthofix Medical, Inc. $1,096 10 payments
  6. Djo, LLC $1,001 12 payments
  7. Horizon Therapeutics plc $695 46 payments
  8. Integra LifeSciences Corporation $587 28 payments
  9. Treace Medical Concepts, Inc. $524 3 payments
  10. HNM Total Recon $481 1 payment
  11. Other $2,609 27 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,169 178 payments
  2. Travel and Lodging $5,379 34 payments
  3. Education $165 2 payments
Products named General payments · program years 2019–2025
  1. INFINITY $1,526 6 payments
  2. Cannulated screws $983 15 payments
  3. TrueLok $940 8 payments
  4. CMF $795 8 payments
  5. InCore Lapidus $792 7 payments
  6. VARIAX $638 3 payments
  7. PROPHECY $603 7 payments
  8. LAPIPLASTY SYSTEM $524 3 payments
  9. ANCHORAGE $434 6 payments
  10. PECA Bunion Correction System $420 2 payments
  11. Other $9,725 289 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

37

Median for Podiatry: 160

Drug cost

$237

Median for Podiatry: $2,368

Branded share of claims

0%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ammonium Lactate Generic 13 $140
Gabapentin Generic 11 $54
Meloxicam Generic 13 $43

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$12,647

Medicare's payments for the services billed

Medicare patients

49

Average age 72

Services billed

189

26 women, 23 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 57%
Diabetes 29%
Ischemic heart disease 27%
Chronic kidney disease 27%
Osteoporosis 27%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

214 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record